Patent · US Active

Benzoimidazol-2-yl pyrimidine derivatives

US9371311B2 · kind B2 · utility

1Cited by
44References
1Claims
0Family size

Assignee

Inventors

Key dates

Filing dateAug 14, 2014
Grant dateJun 21, 2016
Priority date
Expiry dateAug 31, 2034

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07B2200/13
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

The present invention is directed to benzoimidazol-2-yl pyrimidine derivatives useful as histamine H4 receptor modulators and processes for the preparation of such compounds.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.